Literature DB >> 18315420

Clinical evaluation of nanocrystalline hydroxyapatite paste in the treatment of human periodontal bony defects--a randomized controlled clinical trial: 6-month results.

Adrian Kasaj1, Bernd Röhrig, Gregory-George Zafiropoulos, Brita Willershausen.   

Abstract

BACKGROUND: The aim of this study was to compare the clinical outcome of intrabony periodontal defects following treatment with a novel nanocrystalline hydroxyapatite (NHA) paste to open flap debridement.
METHODS: Twenty-eight subjects, each displaying one intrabony defect with probing depth (PD) > or =6 mm and radiographic evidence of an intraosseous component > or =3 mm participated in the present study. Subjects were allocated randomly to treatment with NHA paste (test group) or open flap debridement (control group). At baseline and at 6 months after surgery, the following clinical parameters were recorded by a masked examiner: plaque index, gingival index, PD, clinical attachment level (CAL), and gingival recession.
RESULTS: A significant improvement in PD and CAL was observed at 6 months after surgery compared to baseline in both treatment groups (P <0.001). At 6 months following therapy, the test group showed a reduction in mean PD from 7.4 +/- 1.3 mm to 3.4 +/- 1.2 mm and a change in mean CAL from 8.0 +/- 1.3 mm to 4.4 +/- 1.7 mm, whereas in the control group the mean PD decreased from 7.4 +/- 0.8 mm to 4.9 +/- 0.9 mm, and mean CAL decreased from 8.1 +/- 1.2 mm to 6.4 +/- 1.3 mm. The intergroup comparison demonstrated significantly more PD reductions (P = 0.012) and CAL gains (P = 0.005) in the test group compared to the control group.
CONCLUSION: Treatment of intrabony periodontal defects with NHA paste significantly improved clinical outcomes compared to open flap debridement.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18315420     DOI: 10.1902/jop.2008.070378

Source DB:  PubMed          Journal:  J Periodontol        ISSN: 0022-3492            Impact factor:   6.993


  24 in total

1.  Clinical effects of nanocrystalline hydroxyapatite paste in the treatment of intrabony periodontal defects: a randomized controlled clinical study.

Authors:  Bernd Heinz; Adrian Kasaj; Marie Teich; Søren Jepsen
Journal:  Clin Oral Investig       Date:  2009-08-13       Impact factor: 3.573

2.  Evaluation of OSSIFI® as Alloplastic Bone Graft Material in Treatment of Periodontal Infrabony Defects.

Authors:  Sumit Kaushal; Anoop Kapoor; Preetinder Singh; Gulsheen Kochhar; Nitin Khuller; Patthi Basavaraj
Journal:  J Clin Diagn Res       Date:  2014-10-20

3.  Human periodontal ligament fibroblasts stimulated by nanocrystalline hydroxyapatite paste or enamel matrix derivative. An in vitro assessment of PDL attachment, migration, and proliferation.

Authors:  Adrian Kasaj; Brita Willershausen; Rüdiger Junker; Stefan-Ioan Stratul; Mirko Schmidt
Journal:  Clin Oral Investig       Date:  2011-06-07       Impact factor: 3.573

4.  Histological evaluation of human intrabony periodontal defects treated with an unsintered nanocrystalline hydroxyapatite paste.

Authors:  Attila Horváth; Andreas Stavropoulos; Péter Windisch; László Lukács; István Gera; Anton Sculean
Journal:  Clin Oral Investig       Date:  2012-05-03       Impact factor: 3.573

5.  Comparison of Nano-Sized Hydroxyapatite and β-Tricalcium Phosphate in the Treatment of Human Periodontal Intrabony Defects.

Authors:  Rohit Jain; Harjit Kaur; Sanjiv Jain; Diljit Kapoor; Tarun Nanda; Megha Jain
Journal:  J Clin Diagn Res       Date:  2014-10-20

6.  Clinical evaluation of a biphasic calcium phosphate grafting material in the treatment of human periodontal intrabony defects.

Authors:  Min-Jae Lee; Byung-Ock Kim; Sang-Joun Yu
Journal:  J Periodontal Implant Sci       Date:  2012-08-31       Impact factor: 2.614

7.  Clinical and radiographic evaluation of Nano-crystalline hydroxyapatite bone graft (Sybograf) in combination with bioresorbable collagen membrane (Periocol) in periodontal intrabony defects.

Authors:  Vijendra P Singh; Dilip G Nayak; Ashita S Uppoor; Dipen Shah
Journal:  Dent Res J (Isfahan)       Date:  2012-01

8.  Clinical outcomes after treatment of periodontal intrabony defects with nanocrystalline hydroxyapatite (Ostim) or enamel matrix derivatives (Emdogain): a randomized controlled clinical trial.

Authors:  Elyan Al Machot; Thomas Hoffmann; Katrin Lorenz; Ihssan Khalili; Barbara Noack
Journal:  Biomed Res Int       Date:  2014-02-09       Impact factor: 3.411

9.  Analysis of human alveolar osteoblast behavior on a nano-hydroxyapatite substrate: an in vitro study.

Authors:  Andrea Pilloni; Giorgio Pompa; Matteo Saccucci; Gabriele Di Carlo; Lia Rimondini; Marina Brama; Blerina Zeza; Francesca Wannenes; Silvia Migliaccio
Journal:  BMC Oral Health       Date:  2014-03-20       Impact factor: 2.757

10.  Nano-crystalline hydroxyapatite bone graft combined with bioresorbable collagen membrane in the treatment of periodontal intrabony defects: A randomized controlled clinical trial.

Authors:  Vijendra P Singh; Dilip G Nayak; Ashita S Uppoor; Dipen Shah
Journal:  J Indian Soc Periodontol       Date:  2012-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.